申请人:Abbisko Therapeutics Co., Ltd.
公开号:EP3964518A1
公开(公告)日:2022-03-09
A CD73 inhibitor having the structure represented by formula (I), a preparation method therefor and an application thereof. The series of compounds can be widely applied in the preparation of drugs for treating cancers or tumors that are at least partially mediated by CD73, autoimmune diseases and disorders and metabolic diseases, in particular drugs for treating melanoma, colon cancer, pancreatic cancer, breast cancer, prostate cancer, lung cancer, leukemia, brain tumor, lymphoma, ovarian cancer and Kaposi's sarcoma. A new generation of CD73 inhibitor drugs is expected to be developed.
一种具有公式(I)所表示结构的CD73抑制剂,其制备方法及其应用。该系列化合物可以广泛应用于制备用于治疗至少部分由CD73介导的癌症或肿瘤、自身免疫性疾病和紊乱以及代谢性疾病的药物,特别是用于治疗黑色素瘤、结肠癌、胰腺癌、乳腺癌、前列腺癌、肺癌、白血病、脑瘤、淋巴瘤、卵巢癌和卡波西肉瘤的药物。预计将开发出新一代的CD73抑制剂药物。